Cargando…
Advances in Screening and Development of Therapeutic Aptamers Against Cancer Cells
Cancer has become the leading cause of death in recent years. As great advances in medical treatment, emerging therapies of various cancers have been developed. Current treatments include surgery, radiotherapy, chemotherapy, immunotherapy, and targeted therapy. Aptamers are synthetic ssDNA or RNA. T...
Autores principales: | Li, Zheng, Fu, Xuekun, Huang, Jie, Zeng, Peiyuan, Huang, Yuhong, Chen, Xinxin, Liang, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170048/ https://www.ncbi.nlm.nih.gov/pubmed/34095130 http://dx.doi.org/10.3389/fcell.2021.662791 |
Ejemplares similares
-
Advances in Aptamer-Based Biomarker Discovery
por: Huang, Jie, et al.
Publicado: (2021) -
Strategies for developing long-lasting therapeutic nucleic acid aptamer targeting circulating protein: The present and the future
por: Zhang, Yihao, et al.
Publicado: (2022) -
Establishment of the multi-component bone-on-a-chip: to explore therapeutic potential of DNA aptamers on endothelial cells
por: Fan, Xiaoyu, et al.
Publicado: (2023) -
The Application of Brain Organoids: From Neuronal Development to Neurological Diseases
por: Shou, Yikai, et al.
Publicado: (2020) -
The Application of Microfluidic Technologies in Aptamer Selection
por: Liu, Yang, et al.
Publicado: (2021)